Munkholm, K
Vinberg, M
Kessing, L V
Article History
Received: 1 February 2015
Revised: 11 March 2015
Accepted: 18 March 2015
First Online: 21 July 2015
Competing interests
: LVK has within the preceding 3 years been a consultant for Lundbeck and AstraZeneca. MV has been a consultant for Lundbeck, AstraZeneca, Eli Lilly and Servier. KM declares no conflict of interest.